These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

335 related items for PubMed ID: 25196690

  • 1. Evaluation of headache relief with cosmetic onabotulinumtoxinA injections.
    Goldman ND, Dorton LH, Marcum KK, Gilbert RM, Sandoval LF.
    J Cosmet Dermatol; 2014 Sep; 13(3):224-31. PubMed ID: 25196690
    [Abstract] [Full Text] [Related]

  • 2. Multicenter, randomized, parallel-group study of the safety and effectiveness of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation.
    Carruthers A, Carruthers J, Monheit GD, Davis PG, Tardie G.
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2121-34. PubMed ID: 21134044
    [Abstract] [Full Text] [Related]

  • 3. Multicenter, randomized, parallel-group study of onabotulinumtoxinA and hyaluronic acid dermal fillers (24-mg/ml smooth, cohesive gel) alone and in combination for lower facial rejuvenation: satisfaction and patient-reported outcomes.
    Carruthers J, Carruthers A, Monheit GD, Davis PG.
    Dermatol Surg; 2010 Dec; 36 Suppl 4():2135-45. PubMed ID: 21070457
    [Abstract] [Full Text] [Related]

  • 4. OnabotulinumtoxinA for treatment of chronic migraine: pooled analyses of the 56-week PREEMPT clinical program.
    Aurora SK, Winner P, Freeman MC, Spierings EL, Heiring JO, DeGryse RE, VanDenburgh AM, Nolan ME, Turkel CC.
    Headache; 2011 Oct; 51(9):1358-73. PubMed ID: 21883197
    [Abstract] [Full Text] [Related]

  • 5. Patient Satisfaction and Efficacy of Full-Facial Rejuvenation Using a Combination of Botulinum Toxin Type A and Hyaluronic Acid Filler.
    Molina B, David M, Jain R, Amselem M, Ruiz-Rodriguez R, Ma MY, Kerrouche N, Georgantopoulos SP, Radeau T, Boineau D.
    Dermatol Surg; 2015 Dec; 41 Suppl 1():S325-32. PubMed ID: 26618460
    [Abstract] [Full Text] [Related]

  • 6. Evolution of Facial Aesthetic Treatment Over Five or More Years: A Retrospective Cross-sectional Analysis of Continuous OnabotulinumtoxinA Treatment.
    Carruthers A, Sadick N, Brandt F, Trindade de Almeida AR, Fagien S, Goodman GJ, Raspaldo H, Smith K, Darmody S, Gallagher CJ, Street J, Romagnano L.
    Dermatol Surg; 2015 Jun; 41(6):693-701. PubMed ID: 25973559
    [Abstract] [Full Text] [Related]

  • 7. OnabotulinumtoxinA and Hyaluronic Acid in Facial Wrinkles and Folds: A Prospective, Open-Label Comparison.
    Cohen JL, Swift A, Solish N, Fagien S, Glaser DA.
    Aesthet Surg J; 2019 Jan 17; 39(2):187-200. PubMed ID: 29762642
    [Abstract] [Full Text] [Related]

  • 8. [Wrinkle fillers in cosmetic facial procedures].
    Jaspers GW, Schepers RH, Pijpe J, Jansma J.
    Ned Tijdschr Tandheelkd; 2014 May 17; 121(5):269-74. PubMed ID: 24881255
    [Abstract] [Full Text] [Related]

  • 9. Remodeling of periorbital, temporal, glabellar, and crow's feet areas with hyaluronic acid and botulinum toxin.
    Beer KR, Julius H, Dunn M, Wilson F.
    J Cosmet Dermatol; 2014 Jun 17; 13(2):143-50. PubMed ID: 24910278
    [Abstract] [Full Text] [Related]

  • 10. Hyaluronic acid gel (Restylane) filler for facial rhytids: lessons learned from American Society of Ophthalmic Plastic and Reconstructive Surgery member treatment of 286 patients.
    McCracken MS, Khan JA, Wulc AE, Holds JB, Fante RG, Migliori ME, Ebroon DA, Amato MM, Silkiss RZ, Patel BC.
    Ophthalmic Plast Reconstr Surg; 2006 Jun 17; 22(3):188-91. PubMed ID: 16714927
    [Abstract] [Full Text] [Related]

  • 11. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK, Sadowsky CH, Martinez WC, Zuniga JA, Poulette A.
    Headache; 2012 Sep 17; 52(8):1219-25. PubMed ID: 22607530
    [Abstract] [Full Text] [Related]

  • 12. Predicting migraine responsiveness to botulinum toxin type A injections.
    Kim CC, Bogart MM, Wee SA, Burstein R, Arndt KA, Dover JS.
    Arch Dermatol; 2010 Feb 17; 146(2):159-63. PubMed ID: 20157026
    [Abstract] [Full Text] [Related]

  • 13. Facial rejuvenation after intradermal botulinum toxin: is it really the botulinum toxin or is it the pricks?
    Kapoor R, Shome D, Jain V, Dikshit R.
    Dermatol Surg; 2010 Dec 17; 36 Suppl 4():2098-105. PubMed ID: 21134041
    [Abstract] [Full Text] [Related]

  • 14. Botulinum toxin type a for facial rejuvenation: treatment evolution and patient satisfaction.
    Sepehr A, Chauhan N, Alexander AJ, Adamson PA.
    Aesthetic Plast Surg; 2010 Oct 17; 34(5):583-6. PubMed ID: 20383497
    [Abstract] [Full Text] [Related]

  • 15. The South American Glabellar Experience Study (SAGE): a multicenter retrospective analysis of real-world treatment patterns following the introduction of incobotulinumtoxinA in Argentina.
    Banegas RA, Farache F, Rancati A, Chain M, Gallagher CJ, Chapman MA, Caulkins CA.
    Aesthet Surg J; 2013 Sep 01; 33(7):1039-45. PubMed ID: 23990584
    [Abstract] [Full Text] [Related]

  • 16. A two-phase, retrospective analysis evaluating efficacy of and patient satisfaction with abobotulinumtoxina used to treat dynamic facial rhytides.
    Kiripolsky MG, Peterson JD, Guiha I, Goldman MP.
    Dermatol Surg; 2011 Oct 01; 37(10):1443-7. PubMed ID: 21649790
    [Abstract] [Full Text] [Related]

  • 17. A Comprehensive Approach to Multimodal Facial Aesthetic Treatment: Injection Techniques and Treatment Characteristics From the HARMONY Study.
    Narurkar VA, Cohen JL, Dayan S, Kaminer MS, Rivkin A, Shamban A, Sykes JM, Teller CF, Weinkle SH, Werschler WP, Drinkwater A, Pucci ML, Gallagher CJ.
    Dermatol Surg; 2016 May 01; 42 Suppl 2():S177-91. PubMed ID: 27128246
    [Abstract] [Full Text] [Related]

  • 18. OnabotulinumtoxinA for treatment of chronic migraine: PREEMPT 24-week pooled subgroup analysis of patients who had acute headache medication overuse at baseline.
    Silberstein SD, Blumenfeld AM, Cady RK, Turner IM, Lipton RB, Diener HC, Aurora SK, Sirimanne M, DeGryse RE, Turkel CC, Dodick DW.
    J Neurol Sci; 2013 Aug 15; 331(1-2):48-56. PubMed ID: 23790235
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Subcutaneous vs intramuscular botulinum toxin: split-face randomized study.
    Gordin EA, Luginbuhl AL, Ortlip T, Heffelfinger RN, Krein H.
    JAMA Facial Plast Surg; 2014 Aug 15; 16(3):193-8. PubMed ID: 24699554
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.